LUNDBECK and Otsuka have welcomed the approval of Abilify Maintena (aripiprazole once-monthly long-acting injectable) for the treatment of bipolar 1 disorder.
The new indication is in addition to Abilify Maintena's previous approval for schizophrenia.
THE Pharmacy Board of Australia has opened public consultation on the draft registration standards and guidelines for a proposed Endorsement for scheduled medicines for pharmacists.
AS the Federal Government enters final negotiations for the First Pharmacy Programs Agreement (1PPA), the Remote and Isolated Pharmacist Association Australia (RIPAA) is calling for a dedicated funding pilot to support resident clinical pharmacists in Australia’s most isolated communities.
UK-BASED organisation GenM founder Heather Jackson (pictured) is on a mission to support pharmacies helping women through menopause with its MTick certification and accreditation.